海翔药业(002099.SZ)：累计回购0.27%股份

Core Viewpoint - Haisheng Pharmaceutical (002099.SZ) has announced a share buyback program, reflecting its commitment to enhancing shareholder value through strategic capital management [1] Summary by Categories Share Buyback Details - As of September 30, 2025, the company has repurchased a total of 4,410,000 shares, which represents 0.27% of its total share capital [1] - The highest transaction price during the buyback was 6.29 CNY per share, while the lowest was 5.66 CNY per share [1] - The total amount spent on the buyback reached 26,090,960.52 CNY, excluding transaction fees [1] Compliance and Strategy - The share repurchase is in accordance with relevant laws and regulations, aligning with the company's established buyback plan [1]